ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

イデベノン

Idebenone

HCID 3686
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
58186-27-9
標準SMILES
COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
分子式
C19H30O5
平均分子量
338.4 g/mol
単同位体質量
338.20932405

概要

Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as a ferroptosis inhibitor and an antioxidant. It is a member of 1,4-benzoquinones and a primary alcohol.

名称と識別子

優先名称
Idebenone
IUPAC
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
現地名
イデベノン
英語名
Idebenone
分子式
C19H30O5
分子量
338.44

名称と別名

idebenone58186-27-9IdebenonaRaxone2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dioneIdebenonumSovrimahydroxydecyl ubiquinoneCV 2619Oristar hdu2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinoneCV-2619
名称をさらに表示
アバン2,3-ジメトキシ-5-メチル-6-(10-ヒドロキシデシル)-1,4-ベンゾキノン6-(10-ヒドロキシデシル)-2,3-ジメトキシ-5-メチル-1,4-ベンゾキノン6-(10-ヒドロキシデシル)-2,3-ジメトキシ-5-メチル-2,5-シクロヘキサジエン-1,4-ジオンイデベノン2-(10-ヒドロキシデシル)-5,6-ジメトキシ-3-メチル-1,4-ベンゾキノン6-(10-ヒドロキシデシル)-5-メチル-2,3-ジメトキシ-1,4-ベンゾキノン2-(10-ヒドロキシデシル)-5,6-ジメトキシ-3-メチル-2,5-シクロヘキサジエン-1,4-ジオンイデベノン (JAN)2-(10-ヒドロキシデシル)-5,6-ジメトキシ-3-メチルシクロヘキサ-2,5-ジエン-1,4-ジオンIdebenonAvandebenoneIdebenone powder6-(10-DarumaMnesisQSA-10
6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinoneDTXSID0040678HB6PN45W4JCHEBI:31687NSC-7592282-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone2,5-Cyclohexadiene-1,4-dione, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-DTXCID8020678

物性

構造計算による物性補完中

XLogP
4.3
極性表面積
72.8 Ų
水素結合供与体数
1
水素結合受容体数
5
回転可能結合数
12
重原子数
24
形式電荷
0
複雑度
502

実験および物理化学的性質

CosmeticsCosmetic ingredients (Hydroxydecyl Ubiquinone) -> CIR (Cosmetic Ingredient Review)
LogP2.96
Human DrugsEMA approved medicines: Human medicine
Collision Cross Section · 2 件

181.21 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

178.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
52 · 52-550C
沸点
497.3 · 497.3±45.0 °C(Predicted)
比重(密度)
1.08 · 1.08±0.1 g/cm3(Predicted)
貯蔵温度
room temp
溶解性
DMSO に可溶 (最大 25 mg/ml)。
酸解離定数(Pka)
15.2 · 15.20±0.10(Predicted)
外見
Solid
色
オレンジ
Merck
14 · 14,4888
安定性
-20 °C · -20°C の DMSO 溶液で最大 3 か月間保存できます。

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.

Danger

H228 (25%): Flammable solid [Danger Flammable solids]

P210, P240, P241, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesFlam. Sol. 2 (25%)

毒性情報

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

安全データ

wgk
3
rtecs
GU5290000
hs_code
2933399990
hazard_code
Xi

化学と産業

薬理情報

ATC Code · 3 件

N06BX13

N - Nervous system

QN - Nervous system

Mechanism of Action · 1 件

Idebenone is a synthetic analogue of ubiquinone (also known as Coenzyme Q10), a vital cell antioxidant and essential component of the Electron Transport Chain (ETC). It has been proposed that by interacting with the ETC, idebenone increases ATP production required for mitochondrial function, reduces free radicals, inhibits lipid peroxidation, and consequently protects the lipid membrane and mitochondria from oxidative damage. More specifically, idebenone is thought to transfer electrons directly to complex III of the mitochondrial ETC, thereby circumventing complex I and restoring cellular energy (ATP) generation.

Metabolism/Metabolites · 1 件

Metabolism occurs by means of oxidative shortening of the side chain and by reduction of the quinone ring and conjugation to glucuronides and sulphates. Idebenone shows a high first pass metabolism resulting in conjugates of idebenone (glucuronides and sulphates (IDE-C)) and the Phase I metabolites QS10, QS6, and QS4 as well as their corresponding Phase II metabolites (glucuronides and sulphates (QS10+QS10-C, QS6+QS6-C, QS4+QS4-C)). The main metabolites in plasma are IDE-C and QS4+QS4-C.

MeSH Pharmacological ClassificationNaturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Absorption, Distribution and Excretion · 3 件

After oral administration, idebenone is rapidly absorbed. On repeat dosing, maximum plasma concentrations of idebenone are reached on average within 1 hour (median 0.67 h range: 0.33-2.00 h). Food increases the bioavailability of idebenone by approximately 5-7-fold and i therefore should always be administered with food.

The main route of elimination is metabolism, with the majority of dose excreted via the kidneys as metabolites. After a single or repeated oral dose of 750 mg of idebenone, QS4+QS4-C were the most prominent idebenone-derived metabolites in urine, representing on average between 49.3% and 68.3% of the total administered dose. QS6+QS6 represented 6.45% to 9.46%, whereas QS10+QS10-C and IDE+IDE-C were close to 1% or below.

関連反応

38 件
反応記録を作成
HRID 147968 の反応式
HRID 147968反応物として
HRID 299093 の反応式
HRID 299093生成物として
HRID 370412 の反応式
HRID 370412反応物として
HRID 580246 の反応式
HRID 580246反応物として
HRID 637893 の反応式
HRID 637893生成物として
HRID 637894 の反応式
HRID 637894生成物として
HRID 637895 の反応式
HRID 637895生成物として
HRID 637896 の反応式
HRID 637896生成物として
前へ1 / 5 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
58186-27-9
PubChem CID
3686
DTXSID
DTXSID0040678
ChEMBL
CHEMBL252556
ChEBI
CHEBI:31687
UNII
HB6PN45W4J
EC Number
814-253-7
Nikkaji
J22.706D
化粧品成分の機能
抗酸化物質
InChI
InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
SMILES
C1(=O)C(OC)=C(OC)C(=O)C(C)=C1CCCCCCCCCCO
LogP
3.49 · 3.490 (est)
CAS データベース
58186 · 58186-27-9(CAS DataBase Reference)

化学的性質

化学的特性An odorless yellow-orange crystalline solid. It is highly insoluble in water, but can be easily dissolved in chloroform, methanol, or absolute ethanol. It is also soluble in ethyl acetate, but insoluble in n-hexane.

Experimental data have shown that idebenone passes the blood-brain barrier and is distributed at significant concentrations in cerebral tissue. Following oral administration pharmacologically relevant concentrations of idebenone are detectable in the aqueous humor of the eye.

用途と製造

UsesCIR ingredient: Hydroxydecyl Ubiquinone
応用分野 · 4 件

用途薬理研究用。

説明Idebenone is an organic compound belonging to the quinone family, being similar to coenzyme Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of Alzheimer’s disease and some other cognitive defects. However, these have been not very much progress associated with this indication. It is now also used for the treatment of Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological function. However, this indication is only approved in Canada, not in Europe and US. It is now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy, Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of this drug still demands more evidences.

使用idebenone is an anti-oxidant capable of protecting the skin from a variety of free-radical attacks, including the formation of secondary chemicals that negatively affect skin physiology. It is said to improve intrinsic as well as extrinsic skin damage caused by freeradical formation. Idebenone is a synthetically manufactured form of coenzyme Q10 and has a smaller molecular structure. This allows it to penetrate the skin and apparently the cellular membrane. Clinical studies demonstrate a visible improvement in photodamaged skin, reduced skin roughness and dryness, decreased fine lines and wrinkles, and increased skin hydration. In addition, idebenone helps improve hyperpigmentation because its molecular structure is similar to that of hydroquinone. Although most of the associated benefits are seen primarily in the epidermis, some increase in dermal collagen has also been confirmed. Idebenone has been used for such health-related problems as Alzheimer’s and heart disease.

一般的な説明Idebenone is a short-chain benzoquinone drug. It is a structural relative of ubiquinone (Coenzyme Q10) that protects the CNS from the effects of ischemia via improving brain metabolism. It is reported to be of potential use in the management of patients with cerebral apoplexy, cerebral arteriosclerosis and related disorders.

上流・下流製品情報

上流原料

ヘキサンN,N-ジメチルホルムアミド2,4-ジアミノアゾベンゼン·塩酸塩10-acetoxycarbonyl chlorideクレゾールりん酸二水素カリウムジクロロメタン3,4,5-トリメトキシトルエン

下流製品

Idebenone Sulfate
補足説明 · 1 件

定義ChEBI: Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as an antioxidant and a ferroptosis inhibitor. It is a primary alcohol and a member of 1,4-benzoquinones.